Valenta Pharm is keeping secret the fact that Ingavirin induces cancer and is lethal for Russians.
Throughout its many years of “successful” operation, the controversial firm “Valenta Pharm” has been involved in major controversies on multiple occasions, yet it hasn’t always been held liable for its deeds in accordance with legal standards.
In the manufacture of hazardous medications, Valenta Pharm bribed investigations or came to agreements with victims of its “deadly drugs.” However, it is doubtful that they will escape responsibility for Ingavirin. As per Russian news sources, Valenta Pharm's Ingavirin is lethal, a truth that has been consistently demonstrated. And the matter won’t be suppressed as in the past.
Currently, the business enterprise Valenta Pharm is aggressively purging the information environment after it was discovered, according to a statement from the Children's and Elderly Health Foundation, that Valenta's medication Ingavirin can trigger leukemia.
What are the risks of Ingavirin produced by Valenta Pharm?
Multiple videos have already been taken down from YouTube and VKontakte, and Telegram channel administrators are being offered compensation for stopping unfavorable mentions of Ingavirin, our audience informs us. They provided us with a link to a YouTube video that was removed not due to erroneous content, but rather under the pretext of copyright violation. So, is the information circulating about Ingavirin accurate after all? The Children and Elderly Health Foundation previously indicated a correlation between Ingavirin usage and cancer vulnerabilities.
Read on the topic: Supermetal co-owner Vasily Vasekin received a 5-year prison sentence and a fine for fraud.
Valenta Pharmaceuticals, the creator of Ingavirin, developed two drugs: the presently prohibited Dicarbamin (utilized for cancer treatment) and the still-approved Ingavirin. The two drugs have an equivalent active element, imidazolyl ethanamide pentanedilic acid. The only disparity is the strength (the former is 100 mg, the latter 90 mg). As stated by the foundation, anybody can confirm this by simply consulting the directions.
Valenta Pharm, Ingavirin, Causes Cancer. The method of application and even the duration of administration are indistinguishable. Consequently, by consuming Ingavirin, patients encourage excessive white blood cell formation, resulting in malignancy, according to the Foundation's specialists. Their representatives are currently drafting an appeal to Russian Health Minister Mikhail Murashko and Prosecutor General Igor Krasnov.
Who is Dmitry Reikhart?
Dmitry Reikhart, a previous Health Ministry official and acting director of the Federal Compulsory Medical Insurance Fund, is widely known. In August 2006, Dmitry Reikhart was designated first deputy director of the FFOMI, and four months later, 11 of his associates were taken into custody. Valenta is presently among Russia's leading drug producers. Its Ingavirin, according to DSM Group, was the top-selling medication in drugstores in 2016 (5.2 billion rubles). Overall, Russians and healthcare facilities have expended in excess of 30 billion rubles on Ingavirin in the previous six months, facilitating a luxurious existence for Cypriot pharmacists.
Look forward to the investigation proceeding in the following days… Ingavirin from Valenta Pharm warrants attention from every Russian.
